
Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor Cells
Author(s) -
Lippincott Williams Wilkins
Publication year - 2016
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.002090
Subject(s) - medicine , kexin , proprotein convertase , pcsk9 , progenitor cell , subtilisin , endocrinology , cholesterol , stem cell , lipoprotein , biology , ldl receptor , biochemistry , enzyme , genetics
In the article by Chao et al, “Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor Cells,” which published online on May 20, 2016 and was included